Cha‐Xiang Guan

3.4k total citations · 1 hit paper
96 papers, 2.4k citations indexed

About

Cha‐Xiang Guan is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Cha‐Xiang Guan has authored 96 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 33 papers in Molecular Biology and 27 papers in Immunology. Recurrent topics in Cha‐Xiang Guan's work include Neonatal Respiratory Health Research (19 papers), Inflammation biomarkers and pathways (14 papers) and Eicosanoids and Hypertension Pharmacology (11 papers). Cha‐Xiang Guan is often cited by papers focused on Neonatal Respiratory Health Research (19 papers), Inflammation biomarkers and pathways (14 papers) and Eicosanoids and Hypertension Pharmacology (11 papers). Cha‐Xiang Guan collaborates with scholars based in China, United States and Netherlands. Cha‐Xiang Guan's co-authors include Yong Zhou, Hui‐Hui Yang, Wenjing Zhong, Jia‐Xi Duan, Xinxin Guan, Jian‐Bing Xiong, Chen‐Yu Zhang, Chen‐Chen Sun, Jianxin Jiang and Xiang Fang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Cha‐Xiang Guan

93 papers receiving 2.4k citations

Hit Papers

Sepsis-induced immunosuppression: mechanisms, diagnosis a... 2022 2026 2023 2024 2022 100 200 300

Peers

Cha‐Xiang Guan
Yong Zhou China
Mark J. Paul‐Clark United Kingdom
Charles D. Loftin United States
Narasaiah Kolliputi United States
Lin L. Mantell United States
Justine Newson United Kingdom
Sangwoon Chung United States
Ashley Hale United Kingdom
Yong Zhou China
Cha‐Xiang Guan
Citations per year, relative to Cha‐Xiang Guan Cha‐Xiang Guan (= 1×) peers Yong Zhou

Countries citing papers authored by Cha‐Xiang Guan

Since Specialization
Citations

This map shows the geographic impact of Cha‐Xiang Guan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cha‐Xiang Guan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cha‐Xiang Guan more than expected).

Fields of papers citing papers by Cha‐Xiang Guan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cha‐Xiang Guan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cha‐Xiang Guan. The network helps show where Cha‐Xiang Guan may publish in the future.

Co-authorship network of co-authors of Cha‐Xiang Guan

This figure shows the co-authorship network connecting the top 25 collaborators of Cha‐Xiang Guan. A scholar is included among the top collaborators of Cha‐Xiang Guan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cha‐Xiang Guan. Cha‐Xiang Guan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Jiajia, Chun Luo, Kunbo Wang, et al.. (2025). Unraveling the mechanisms of NINJ1-mediated plasma membrane rupture in lytic cell death and related diseases. International Journal of Biological Macromolecules. 309(Pt 4). 143165–143165. 1 indexed citations
3.
Guan, Cha‐Xiang, Yuexuan Zhang, Shiyi Wang, et al.. (2025). Identification of crucial genes sustaining the curled leaf phenotype in perennial transgenic poplar via advanced proteomic and phosphoproteomic analyses. Journal of Proteomics. 319. 105471–105471. 1 indexed citations
4.
Zhong, Wenjing, Chenyu Zhang, Jia‐Xi Duan, et al.. (2024). Krüppel-like transcription factor 14 alleviates alveolar epithelial cell senescence by inhibiting endoplasmic reticulum stress in pulmonaryfibrosis. International Journal of Biological Macromolecules. 280(Pt 1). 135351–135351. 2 indexed citations
5.
Jiang, Huiling, Hui‐Hui Yang, Jia‐Xi Duan, et al.. (2024). CGRP is essential for protection against alveolar epithelial cell necroptosis by activating the AMPK/L‐OPA1 signaling pathway during acute lung injury. Journal of Cellular Physiology. 239(2). e31169–e31169. 5 indexed citations
6.
Jin, Ling, Bo‐Ying Bao, Xiaoting Huang, et al.. (2024). MEOX1 triggers myofibroblast apoptosis resistance, contributing to pulmonary fibrosis in mice. Journal of Cellular Physiology. 239(12). e31442–e31442. 3 indexed citations
7.
Qiu, Yanling, Wenjing Zhong, Chen‐Yu Zhang, et al.. (2024). Neutrophil extracellular traps trigger alveolar epithelial cell necroptosis through the cGAS-STING pathway during acute lung injury in mice. International Journal of Biological Sciences. 20(12). 4713–4730. 19 indexed citations
8.
Guan, Xinxin, Hui‐Hui Yang, Wenjing Zhong, et al.. (2022). Fn14 exacerbates acute lung injury by activating the NLRP3 inflammasome in mice. Molecular Medicine. 28(1). 85–85. 9 indexed citations
9.
Zhou, Yong, et al.. (2022). Megakaryocytes in pulmonary diseases. Life Sciences. 301. 120602–120602. 6 indexed citations
10.
Liu, Tian, Chen‐Yu Zhang, Cheng Zu, et al.. (2022). Epoxyeicosatrienoic Acids Inhibit the Activation of Murine Fibroblasts by Blocking the TGF‐β1‐Smad2/3 Signaling in a PPARγ‐Dependent Manner. Oxidative Medicine and Cellular Longevity. 2022(1). 7265486–7265486. 14 indexed citations
11.
Ma, Tianliang, Yong Zhou, Jingxian Chen, et al.. (2021). Targeting Ferroptosis for Lung Diseases: Exploring Novel Strategies in Ferroptosis‐Associated Mechanisms. Oxidative Medicine and Cellular Longevity. 2021(1). 1098970–1098970. 30 indexed citations
12.
Wan, Li, Haican Liu, Machao Li, et al.. (2020). Genomic Analysis Identifies Mutations Concerning Drug-Resistance and Beijing Genotype in Multidrug-Resistant Mycobacterium tuberculosis Isolated From China. Frontiers in Microbiology. 11. 1444–1444. 17 indexed citations
13.
Yang, Hui‐Hui, Jia‐Xi Duan, Shaokun Liu, et al.. (2020). A COX-2/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation. Theranostics. 10(11). 4749–4761. 162 indexed citations
14.
Yang, Hui‐Hui, Chenyu Zhang, Jian‐Bing Xiong, et al.. (2019). Exogenous angiotensin (1-7) directly inhibits epithelial-mesenchymal transformation induced by transforming growth factor-β1 in alveolar epithelial cells. Biomedicine & Pharmacotherapy. 117. 109193–109193. 36 indexed citations
15.
Wan, Li, Shuangshuang Chen, Zhiguang Liu, et al.. (2016). [Analysis on drug resistance of Mycobacterium tuberculosis and influencing factors in six provinces of China].. PubMed. 37(7). 945–8. 2 indexed citations
16.
Zhou, Yong, Guo-Ying Sun, Tian Liu, et al.. (2015). Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice. Cell and Tissue Research. 363(2). 399–409. 59 indexed citations
17.
Han, Jianzhong, Chen Li, Huijun Liu, et al.. (2008). Inhibition of lipopolysaccharide‐mediated rat alveolar macrophage activation in vitro by antiflammin‐1. Cell Biology International. 32(9). 1108–1115. 7 indexed citations
18.
Li, Lian, Hua She, Shaojie Yue, et al.. (2007). Role of c-fos gene in vasoactive intestinal peptide promoted synthesis of pulmonary surfactant phospholipids. Regulatory Peptides. 140(3). 117–124. 12 indexed citations
19.
Li, Lian, et al.. (2004). Effect of vasoactive intestinal peptide on pulmonary surfactants phospholipid synthesis in lung explants.. PubMed. 25(12). 1652–8. 13 indexed citations
20.
Slater, Cristin C., Irene Souter, Chunying Zhang, et al.. (2001). Pharmacokinetics of testosterone after percutaneous gel or buccal administration. Fertility and Sterility. 76(1). 32–37. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026